1,177
Views
10
CrossRef citations to date
0
Altmetric
Review Article

Therapeutic challenges in ocular delivery of lipid based emulsion

, , , &
Pages 121-129 | Received 02 Feb 2018, Accepted 01 Apr 2018, Published online: 06 Mar 2019

References

  • Ameeduzzafar, Ali J, Fazil M, Qumbar M, Khan N, Ali A. Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv 2016;23:700–16.
  • G.HorvátB.GyarmatiS.BerkóP.Szabó-RévészB.Á.SzilágyiA.Szilágyiet al.Thiolated poly (aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery systemEur J Pharm Sci672015 1-1
  • J.F.FangueiroT.AndreaniM.A.EgeaM.L.GarciaS.B.SoutoA.M.Silvaet al.Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicityInt J Pharm46120146473
  • R.ZhaoJ.LiJ.WangZ.YinY.ZhuW.LiuDevelopment of timolol-loaded galactosylated chitosan nanoparticles and evaluation of their potential for ocular drug deliveryAAPS PharmSciTech1820179971008
  • Yancopoulos GD, inventor; Regeneron Pharmaceuticals Inc, assignee. Use of a VEGF antagonist to treat angiogenic eye disorders. United States patent US 9,669,069. 2017.
  • F.D.BattistiniL.I.TártaraC.BoieroM.L.GuzmánL.C.Luciani-GiaccobbeS.D.Palmaet al.The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model caseEur J Pharm Sci1052017188194
  • M.SharmaK.NagoriS.SoniV.S.VermaA.SinghHerbal Significance and Home Remedies to Treat Conjunctivitis: An OverviewRJTCS5201430
  • V.K.YellepeddiS.PalakurthiRecent advances in topical ocular drug deliveryJ Ocul Pharmacol Ther3220166782
  • H.AlmeidaM.H.AmaralP.LobãoJ.M.LoboIn situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulationsDrug Discov Today192014400412
  • M.Pera-TitusL.LeclercqJ.M.ClacensF.De CampoV.Nardello-RatajPickering interfacial catalysis for biphasic systems: from emulsion design to green reactionsAngew Chem Int Ed54201520062021
  • A.MadniM.A.RahemN.TahirM.SarfrazA.JabarM.Rehmanet al.Non-invasive strategies for targeting the posterior segment of eyeInt J Pharm5302017326345
  • P.DaullF.LallemandJ.S.GarrigueBenefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug deliveryJ Pharm Pharmacol662014531541
  • Lallemand F, Garrigue JS, Philips B, inventors; Santen Sas, assignee. Water-in oil type emulsion for treating a disease of the eye. United States patent US 9,107,822. 2015.
  • Bachu RD, Stepanski M, Alzhrani RM, Jung R, Boddu SH. Development and evaluation of a novel microemulsion of dexamethasone and tobramycin for topical ocular administration. J Ocul Pharmacol Ther; 2018. doi:http://doi.org/10.1089/jop.2017.0082. [Epub ahead of print].
  • K.C.AsharaK.V.ShahEmulsion of chloramphenicol: an overwhelming approach for ocular deliveryFolia Med5920172330
  • G.V.GomesM.R.SolaL.F.MarosteganC.G.JangeC.P.CazadoA.C.Pinheiroet al.Physico-chemical stability and in vitro digestibility of beta-carotene-loaded lipid nanoparticles of cupuacu butter (Theobroma grandiflorum) produced by the phase inversion temperature (PIT) methodJ Food Eng192201793102
  • A.K.SharmaT.GargA.K.GoyalG.RathRole of microemuslsions in advanced drug deliveryArtif Cells Nanomed Biotechnol44201611771185
  • Fielder A, Blencowe H, O'connor A, Gilbert C. Impact of retinopathy of prematurity on ocular structures and visual functions. Arch Dis Child Fetal Neonatal Ed 2014;fetalneonatal-2014.
  • Y.JiaS.T.BaileyD.J.WilsonO.TanM.L.KleinC.J.Flaxelet al.Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degenerationOphthalmology121201414351444
  • S.MitragotriP.A.BurkeR.LangerOvercoming the challenges in administering biopharmaceuticals: formulation and delivery strategiesNat Rev Drug Discov132014655672
  • E.Sánchez-LópezM.EspinaS.DoktorovovaE.B.SoutoM.L.GarcíaLipid nanoparticles (SLN, NLC): overcoming the anatomical and physiological barriers of the eye–part I–barriers and determining factors in ocular deliveryEur J Pharm Biopharm11020177075
  • N.AkhtarR.Kumar SinghK.PathakExploring the potential of complex-vesicle based niosomal ocular system loaded with azithromycin: Development of in situ gel and ex vivo characterizationPharm Biomed Res320172233
  • Mshimesh BA. A comparative study between atropine and tropicamide as cycloplegic agents for a sample of Iraqi children. Iraqi J Med Sci; 2016:14.
  • A.HueckR.WehrmannComparison of the clinical efficacy of four different liposomal sprays for the treatment of dry eyeOpen J Ophthalmol72017103
  • J.van RooijR.J.WubbelsW.P.de KruijfA new spray device to deliver topical ocular medication: penetration of fluorescein to the anterior segmentJ Ocul Pharmacol Ther312015531535
  • N.M.FarandosA.K.YetisenM.J.MonteiroC.R.LoweS.H.YunContact lens sensors in ocular diagnosticsAdv Healthc Mater42015792810
  • R.KumarSinha V.RanjanEvaluation of ocular irritation and bioavailability of voriconazole loaded microemulsionCurr Drug Deliv142017718724
  • Tiwari R, Dubey V, Kesavan K. Ocular self-microemulsifying drug delivery system of prednisolone improves therapeutic effectiveness in the treatment of experimental uveitis. Ocular Immunol Inflammation 2017:1–9.
  • P.JainP.RahiV.PandeyS.AsatiV.SoniNanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effectsEJBAS4201789100
  • D.BansalK.YadavV.PandeyA.GaneshpurkarA.AgnihotriN.DubeyLactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinomaDrug Deliv232016140146
  • M.A.MoustafaY.S.ElnaggarW.M.El-RefaieO.Y.AbdallahHyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effectInt J Pharm53420171424
  • P.ChetoniD.MontiS.TampucciB.MatteoliL.Ceccherini-NelliA.Subissiet al.Liposomes as a potential ocular delivery system of distamycin AInt J Pharm4922015120126
  • Y.DongP.DongD.HuangL.MeiY.XiaZ.Wanget al.Fabrication and characterization of silk fibroin-coated liposomes for ocular drug deliveryEur J Pharm Biopharm9120158290
  • Y.ChenJ.TuoH.HuangD.LiuX.YouJ.Maiet al.Optimized mixed oils remarkably reduce the amount of surfactants in microemulsions without affecting oral bioavailability of ibuprofen by simultaneously enlarging microemulsion areas and enhancing drug solubilityInt J Pharm48720151724
  • Farid RM, El-Salamouni NS, El-Kamel AH, El-Gamal SS. Lipid-based nanocarriers for ocular drug delivery. Nanostructures Drug Delivery 2017;495–522).
  • Sharma UK, Verma A, Prajapati SK, Pandey H. Ocular drug delivery: assorted obstructions and contemporary progresse. 2013.
  • S.MishimaA.GassetS.D.KlyceJ.L.BaumDetermination of tear volume and tear flowInvest Ophthalmol Vis Sci51966264276
  • H.OnoderaS.SasakiS.OtakeM.TomohiroK.ShibuyaM.NomuraGeneral considerations in ocular toxicity risk assessment from the toxicologists’ viewpointsJ Toxicol Sci402015295307
  • V.AgrahariA.MandalV.AgrahariH.M.TrinhM.JosephA.Rayet al.A comprehensive insight on ocular pharmacokineticsDrug Deliv Transl Res62016735754
  • I.RodríguezJ.A.VázquezL.PastranaV.V.KhutoryanskiyEnhancement and inhibition effects on the corneal permeability of timolol maleate: polymers, cyclodextrins and chelating agentsInt J Pharm5292017168177
  • J.PakZ.J.ChenK.SunA.PrzekwasR.WalengaJ.FanComputational modeling of drug transport across the in vitro corneaComput Biol Med922018139146
  • S.RönkköK.S.VellonenK.JärvinenE.ToropainenA.UrttiHuman corneal cell culture models for drug toxicity studiesDrug Deliv Transl Res62016660675
  • D.Nabih MariaS.R.MishraL.WangA.E.Helmy Abd-ElgawadO.Abd-Elazeem SolimanM.Salah El-Dahanet al.Water-soluble complex of curcumin with cyclodextrins: enhanced physical properties for ocular drug deliveryCurr Drug Deliv142017875886
  • K.HörmannA.ZimmerDrug delivery and drug targeting with parenteral lipid nanoemulsions—A reviewJ Control Release22320168598
  • N.Üstündağ-OkurE.H.GökçeD.İ.BozbıyıkS.EğrilmezÖ.ÖzerG.ErtanPreparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitisEur J Pharm Sci632014204215
  • N.PatelH.NakraniM.RavalN.ShethDevelopment of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailabilityDrug Deliv23201637123723
  • S.K.BhartiK.KesavanPhase-transition W/O microemulsions for ocular delivery: evaluation of antibacterial activity in the treatment of bacterial keratitisOcul Immunol Inflamm252017463474
  • K.KesavanS.KantJ.K.PanditTherapeutic effectiveness in the treatment of experimental bacterial keratitis with ion-activated mucoadhesive hydrogelOcul Immunol Inflamm242016489492
  • P.JaiswalB.GidwaniA.VyasNanostructured lipid carriers and their current application in targeted drug deliveryArtif Cells Nanomed Biotechnol4420162740
  • N.LidichE.J.WachtelA.AserinN.GartiWater-dilutable microemulsions for transepithelial ocular delivery of riboflavin phosphateJ Colloid Interface Sci4632016342348
  • S.KalepuM.ManthinaV.PadavalaOral lipid-based drug delivery systems–an overviewActa Pharm Sin B32013361372
  • S.K.KimChitin and chitosan derivatives: advances in drug discovery and developments2013CRC Press
  • H.K.SyedK.K.PehIdentification of phases of various oil, surfactant/co-surfactants and water system by ternary phase diagramActa Pol Pharm712014301309
  • A.MaazS.TrefiM.HarounW.AbdelwahedPreparation of gatifloxacin microparticles by double emulsification w/o/w method for ocular drug delivery: influence of preparation parametersRJPT10201712771288
  • Z.HouY.GaoF.YuanY.LiuC.LiD.XuInvestigation into the physicochemical stability and rheological properties of β-carotene emulsion stabilized by soybean soluble polysaccharides and chitosanJ Agric Food Chem58201086048611
  • Aberg AG, Ciofalo VB, Johnson K, inventors; Bridge Pharma Inc, assignee. Formulations and methods for treating high intraocular pressure. United States patent US 9,694,003. 2017 Jul 4.
  • Salimi A, Panahi-Bazaz MR, Panahi-Bazaz E. A novel microemulsion system for ocular delivery of azithromycin: design, characterization and ex-vivo rabbit corneal permeability. Jundishapur J Nat Pharm Prod 2017;12.
  • M.A.KalamA.AlshamsanI.A.AljuffaliA.K.MishraY.SultanaDelivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determinationDrug Deliv232016886897
  • M.D.ChatzidakiN.ArikJ.MonteilV.PapadimitriouF.Leal-CalderonA.XenakisMicroemulsion versus emulsion as effective carrier of hydroxytyrosolColloids Surf B1372016146151
  • L.NarayanaN.ChellaD.KumarN.R.ShastriDesign of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficientJ Liposome Res252015325333
  • X.DongQ.ZhuY.DaiJ.HeH.PanJ.Chenet al.Encapsulation artocarpanone and ascorbic acid in O/W microemulsions: preparation, characterization, and antibrowning effects in apple juiceFood Chem192201610331040
  • M.JaiswalR.DudheP.K.SharmaNanoemulsion: an advanced mode of drug delivery system. 3Biotech52015123127
  • J.M.GutierrezC.GonzálezA.MaestroI.SoleC.M.PeyJ.NollaNano-emulsions: new applications and optimization of their preparationCurr Opin Colloid Interface Sci132008245251
  • S.M.JafariE.AssadpoorY.HeB.BhandariRe-coalescence of emulsion droplets during high-energy emulsificationFood Hydrocoll22200811911202
  • L.Salvia-TrujilloA.Rojas-GraüR.Soliva-FortunyO.Martín-BellosoPhysicochemical characterization and antimicrobial activity of food-grade emulsions and nanoemulsions incorporating essential oilsFood Hydrocoll432015547556
  • C.PugliaA.OffertaC.CarboneF.BoninaR.PignatelloG.PuglisiLipid nanocarriers (LNC) and their applications in ocular drug deliveryCurr Med Chem22201515891602
  • Kaswan R, inventor. University of Georgia Research Foundation Inc (UGARF), assignee.Ophthalmic treatment by topical administration of cyclosporin. United States patent US 4,649,047. 1987.
  • Benita S, Elbaz E, inventors. Yissum Research Development Co of Hebrew University, assignee. Oil-in-water emulsions of positively charged particles. United States patent US 6,007,826. 1999.
  • Simonnet JT, Sonneville O, Legret S, L'Oreal SA. Nanoemulsion based on oxyethylenated or non-oxyethylenatedsorbitan fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields. U.S. Patent 6,335,022. 2002.
  • Benita S, Lambert G, inventors; Novagali SA. Yissum Research Development Co of Hebrew University, assignee. Method and composition for dry eye treatment. United States patent US 6,656,460. 2003.
  • Carli F, Baronian M, Schmid R, Chiellini E, inventors. Azad Pharma Ag, assignee. Ophthalmic oil-in-water emulsions containing prostaglandins. United States patent US 8,414,904. 2013.
  • Jain S, Kompella UB, Musunuri S, inventors. Ocugen Inc, University of Illinois, assignee. Methods and compositions for treating dry eye disease and other eye disorders. United States patent US 9,597,328. 2017.
  • A.A.AbdelbaryW.H.Abd-ElsalamA.M.Al-mahallawiFabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessmentInt J Pharm5132016688696
  • H.ShresthaR.BalaS.AroraLipid-based drug delivery systemsJ Pharm20142014
  • N.GautamK.KesavanDevelopment of microemulsions for ocular deliveryTher Deliv82017313330
  • R.KhanumH.ThevanayagamLipid peroxidation: its effects on the formulation and use of pharmaceutical emulsionsAsian J Pharm Sci122017401411
  • K.HippalgaonkarS.MajumdarV.KansaraInjectable lipid emulsions—advancements, opportunities and challengesAAPS Pharmscitech11201015261540
  • M.RuponenA.UrttiUndefined role of mucus as a barrier in ocular drug deliveryEur J Pharm Biopharm962015442446
  • X.ZhangY.ZhangT.ZhangJ.ZhangB.WuSignificantly enhanced bioavailability of niclosamide through submicron lipid emulsions with or without PEG-lipid: a comparative studyJ Microencapsul322015496502